A specialist investment firm

Building institutional access to women's health.

Calabar brings institutional investment discipline and specialist expertise to the opportunities emerging across women's health.

Meet the leadership Submit your pitch deck

Calabar Capital is an investment platform currently in development.

02 — Investment Leadership

Investment experience supported by institutional governance.

Maryann Selfe, FCCA

Founder, Managing Partner and Chief Investment Officer

Maryann leads Calabar's investment strategy and portfolio construction, bringing more than 20 years of experience across institutional investing and private wealth. At Credit Suisse, she advised $700 million in client assets and oversaw investment risk across approximately $100 billion in multi-asset portfolios. She later served on the Management Committee of BIL Suisse and chaired its Swiss Investment Committee.

She combines this institutional background with direct investment experience in women's health and a specialist network spanning founders, clinicians, researchers and industry leaders. She is the author of The Billion Dollar Blindspot and founder of FemmeHealth Alliance.

More about Maryann

Jillian MacNab

Co-Founder, Head of Governance and Operations

Jillian leads Calabar's governance and operational development. A Swiss financial-services lawyer, she brings more than twenty-five years of experience across regulation, investment structures and institutional governance.

Jillian MacNab on LinkedIn

Investment Committee

Institutional discipline informed by specialist expertise.

Calabar's Investment Committee brings together expertise in portfolio construction, women's health venture investing, commercialisation and international healthcare markets.

Maryann Selfe, Chair of the Investment Committee at Calabar Capital

Maryann Selfe, FCCA

Chair, Investment Committee

Maryann chairs the Investment Committee and leads Calabar's investment assessment and portfolio construction. She oversees due diligence and investment decisions, evaluating each opportunity's merits, capital requirements, portfolio fit and risk.

Dominnique Karetsos

Investment Committee Member

Women's-Health Venture Investing and Commercialisation

Dominnique Karetsos is co-creator of Amboy Street Ventures and served as General Partner of Fund I (2019–2025), bringing extensive experience investing in women's and sexual health companies. As founder of Healthy Pleasures Group, she also brings hands-on operating and company-building experience in the sector. Her expertise spans investment assessment, commercial strategy and supporting companies as they scale.

Sara Zhou

Investment Committee Member

Cross-Border Healthcare Investing

Sara Zhou is a cross-border healthcare investor and adviser with deep networks across the United States, Europe and Asia. A former Investment Director at Shanghai Creation Investment, she helped establish four overseas funds totalling $50 million and led due diligence on more than 20 global healthcare investments.

Advisers

Guided by specialist and institutional perspective.

Calabar's advisers extend the firm's expertise beyond investment selection, providing independent perspectives on institutional wealth, clinical relevance and healthcare adoption.

Dr Mara Catherine Harvey

Dr Mara Catherine Harvey brings more than 25 years of international wealth-management leadership, including experience as a private-banking CEO and Supervisory Board member. Her expertise in family wealth, intergenerational transfer, impact finance and financial inclusion brings an important private-wealth and institutional-allocation perspective to Calabar Capital.

Dr Abraham (Nick) Morse

Dr Abraham (Nick) Morse is a Harvard-trained physician and women's-health specialist with more than 25 years of experience across clinical practice, digital health and healthcare innovation. He advises Calabar Capital on clinical developments, healthcare delivery and the translation of scientific advances into scalable businesses.

03 — The Investment Thesis

Longstanding gaps in women's health are becoming investable opportunities.

Historical underinvestment has left longstanding gaps in women's health.

Today, advances in sex-specific science and technology, together with demographic shifts, are translating these gaps into investable opportunities.

A growing market

PwC estimates the broader global women's-health market at approximately $430–$440 billion today, with the potential to exceed $600 billion by 2030.

Specialist innovation

Specialist companies are developing new diagnostics, therapeutics, medical devices and models of care across women's health.

Fragmented access

Opportunities span clinical disciplines, sectors and geographies. Accessing them requires specialist networks and expertise in assessing scientific evidence and commercial potential.

Source: PwC, 2026. Market estimate includes core women's health and major adjacent conditions.

04 — Selected Research

Research that sharpens investment judgement.

Investing in women's health requires more than recognising unmet need. It requires an understanding of how the market is developing, where specialist expertise sits and how different opportunities contribute to an investment portfolio.

Calabar's research examines market structure, capital flows, specialist manager ecosystems and the portfolio implications of investing across women's health. Maryann publishes selected analysis through The Billion Dollar Blindspot.

Research01

How to Invest in Women's Health

An institutional framework for the principal routes available to investors—and the different risks, capabilities and portfolio implications of each.

Read the Article

Research02

Is Women's Health a Good Investment Opportunity for Private Wealth?

An assessment of the opportunity through the lens of demand, capital flows, portfolio construction and private-wealth allocation.

Read the Article

Research03

Women's Health Capital Review — September 2026

A review of funding rounds, strategic transactions and clinical and regulatory developments, examining where capital is flowing and what these signals mean for investors in women's health.

Read the Article

Explore The Billion Dollar Blindspot

05 — Contact

Start a conversation.

We welcome enquiries from investors, founders and industry partners across women's health.

For founders

Building a company in women's health? Submit your pitch deck to introduce your business to Calabar Capital.

Submit your pitch deck

Get in touch

For investment, partnership, company introductions or media enquiries, please contact: hello@calabarcapital.com